Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants.
Schweizer
R T
RT
Hartford Transplant Center, Hartford Hospital, Connecticut 06102-5037.
Bartus
S
S
Hull
D
D
Perdrizet
G
G
Roper
L
L
D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
D016853:Muromonab-CD3; D016572:Cyclosporine; D008775:Methylprednisolone